Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 7 | 0 | 2,440 | 874 | 489 |
| Gross Profit | 7 | 0 | 2,440 | 874 | 489 |
| Operating Expenses | 10,993 | 9,729 | 7,449 | 6,606 | 5,207 |
| Operating Income | -10,986 | -9,729 | -5,009 | -5,732 | -4,718 |
| Other Income | 149 | 52 | 22 | 13 | 14 |
| Pre-tax Income | -10,837 | -9,677 | -4,987 | -5,719 | -4,704 |
| Income Tax | -145 | -147 | -200 | -35 | -15 |
| Net Income Continuous | -10,692 | -9,530 | -4,787 | -5,684 | -4,689 |
| Net Income | $-10,692 | $-9,530 | $-4,787 | $-5,684 | $-4,689 |
| EPS Basic Total Ops | -14.05 | -12.61 | -6.84 | -9.00 | -7.56 |
| EPS Basic Continuous Ops | -14.13 | -13.00 | -6.75 | -8.97 | -7.40 |
| EPS Diluted Total Ops | -14.05 | -12.61 | -6.84 | -9.00 | -7.56 |
| EPS Diluted Continuous Ops | -14.13 | -13.00 | -6.75 | -8.97 | -7.40 |
| EBITDA(a) | $-10,323 | $-9,488 | $-4,815 | $-5,539 | $-4,525 |